SCHEMBL1063647

SCHEMBL1063647

CCCCCC(N)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27914912 0.98 OPRM1 (0.48)
SCHEMBL27897570 0.98 OPRM1 (0.48)
SCHEMBL3325908 0.98 OPRM1 (0.48)
SCHEMBL11298285 0.98 OPRM1 (0.48)
SCHEMBL28801700 0.98 OPRM1 (0.48)
SCHEMBL381494 0.98 OPRM1 (0.48)
SCHEMBL3326811 0.98 OPRM1 (0.48)
SCHEMBL1664514 0.98 OPRM1 (0.48)
SCHEMBL3092823 0.98 OPRM1 (0.48)
SCHEMBL9828480 0.98 OPRM1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4681737-B2 2011-05-11 JP claimed
US-20070225291-A1 Substituted Pyrazinone Compounds for the Treatment of Inflammation PFIZER INC. 2007-09-27 US claimed
EP-1678164-B1 SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORP (US) 2007-04-11 EP claimed
EP-1678146-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2006-07-12 EP claimed
EP-1678164-A1 SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2006-07-12 EP claimed
EP-1667700-A2 CYCLIC PEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF SEXUAL DYSFUNCTION Palatin Technologies, Inc. (US) 2006-06-14 EP claimed
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US claimed
US-20050164914-A1 Metallopeptide compositions for treatment of sexual dysfunction PALATIN TECHNOLOGIES, INC. (US) 2005-07-28 US claimed
WO-2005040133-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-05-06 WO claimed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO claimed
WO-2005035527-A1 SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-21 WO claimed
WO-2005014617-A2 CYCLIC PEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF SEXUAL DYSFUNCTION PALATIN TECHNOLOGIES, INC. (US) 2005-02-17 WO claimed
US-6777408-B1 AFFINITY AND SELECTIVITY FOR SOMATOSTATIN RECEPTORS; SUCH AS 5-(2-CHLOROPHENYL)-1,3,6,7,8,9-HEXAHYDRO-1-(2-PHENYLETHYL)-2H -PYRIDO(4',3':4,5)THIENO(2,3-E)-1,4-DIAZEPINE-2-ONE SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-08-17 US claimed
US-20040138136-A1 Cyclic peptide compositions and methods for treatment of sexual dysfunction PALATIN TECHNOLOGIES, INC. 2004-07-15 US claimed
WO-2004005324-A2 PEPTIDE COMPOSITION FOR TREATMENT OF SEXUAL DYSFUNCTION PALATIN TECHNOLOGIES, INC. (US) 2004-01-15 WO claimed
EP-1171444-B1 PYRIDO-THIENO-DIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID PYRIDO-THIENO-DIAZEPINES SOD CONSEILS RECH APPLIC (FR) 2003-07-02 EP claimed
EP-1171444-A1 PYRIDO-THIENO-DIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID PYRIDO-THIENO-DIAZEPINES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-01-16 EP claimed
WO-2000061587-A1 PYRIDO-THIENO-DIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID PYRIDO-THIENO-DIAZEPINES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2000-10-19 WO claimed
WO-2024086381-A2 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO, INC. (US) 2024-04-25 WO disclosed
EP-0675133-A1 13-Substituted milbemycin derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1995-10-04 EP disclosed